April 18, 2019: The global gene therapy market size is expected to reach USD 5.55 billion by 2026, growing at a CAGR of 33.9% over the forecast period, according to a new report by Radiant Insights, Inc. Gene therapy is being developed with an aim to identify and cure rare conditions, diseases that have limited treatment options and that need lifelong medication to keep the symptoms in check. For instance, metabolic disorders like lysosomal diseases need constant medical attention with the medication available now, however, gene therapy might become a one-time cure to such diseases.
To Request A Sample Copy Of This Report @:
There are a number of molecules under development due to intense competition. This factor is projected to be the key factor propelling the market growth. In early 2018, there were more than 950 molecules in the pipeline with various regulatory bodies in various clinical phases. However, around 76% of the molecules are in the developmental or preclinical stages and are expected to be available by the late 2020s. Larger pharma/biotech companies are entering into the market by either acquiring the licensing/manufacturing rights from smaller companies that are solely dedicated to gene therapy research or by building a dedicated research portfolio with investments and clinical trials.
These factors are also expected to boost the market growth over the next two decades. Most of the manufacturers are also developing molecules that can help cure various cancers. Growing prevalence of different types of cancer emphasizes the need for the development of robust treatment options. Ongoing developments in cancer gene studies have provided significant information about cancer-related molecular signatures, which in turn, is expected to support the ongoing clinical trials for cancer therapeutics.
Further key findings from the study suggest:
• 7 gene therapy molecules have been approved by various regulatory bodies. In 2018, the FDA approved 3 molecules
• Lentivirus is being used as viral vector of choice for 2 of the 3 molecules approved by the FDA
• U.S. and Europe are expected to occupy the largest market shares over the forecast period owing to gene therapy molecules being marketed in these regions
• Europe is set to grow at a fast pace due to the growing pipeline molecules and a number of companies competing in the regional market
• Key companies in the market are Novartis AG, Gilead Sciences, Inc.; UniQure N.V.; Spark Therapeutics LLC; Bluebird Bio; Juno Therapeutics; GlaxoSmithKline PLC; Celgene Corporation; Shire PLC; Sangamo Biosciences, Inc.; Dimension Therapeutics, Inc.; Voyager Therapeutics, Inc.; Human Stem Cell Institute; Chiesi Farmaceutici S.p.A.; and Bristol-Myers Squibb Company
Table of Contents
Chapter 1. Research Methodology
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2. Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3. Gene Therapy Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis, by Stage
3.4 Industry Analysis
3.4.1 Cost structure analysis
3.4.2 User perspective analysis
3.4.2.1 Consumer behavior analysis
3.4.2.2 Market influencer analysis
3.4.3 Procedure cost analysis
3.5 Technology Overview
3.5.1 Technology timeline
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards & compliance
3.6.3 Safety
3.7 Market Dynamics
3.7.1 Market driver analysis
3.7.1.1 Robust pipeline in development
3.7.1.2 Introduction of technological advancements
3.7.1.3 Increasing investment from the companies and partnerships
3.7.1.4 Growing prevalence of target diseases and increased demand for innovative medicine
3.7.2 Market restrain analysis
3.7.2.1 Presence of ambiguous regulatory framework
3.7.2.2 High prices of gene therapy medicines
3.7.3 Industry challenges
3.7.3.1 High cost of development
3.7.3.2 Vector availability
3.8 Gene Therapy Market Analysis Tools
3.8.1 Industry Analysis – Porter’s
3.8.1.1 Supplier power – High
3.8.1.2 Buyer power – Medium
3.8.1.3 Substitution threat – High
3.8.1.4 New entrants threat – Medium
3.8.2 PESTEL analysis
3.8.2.1 Political Landscape
3.8.2.2 Environmental Landscape
3.8.2.3 Social Landscape
3.8.2.4 Technology Landscape
3.8.2.5 Legal Landscape
3.8.3 Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4 Market entry strategies
3.8.5 Case studies
To See More Reports of This Category by Radiant Insights:
https://www.radiantinsights.com/catalog/biotechnology
About Radiant Insights:
https://www.radiantinsights.com/catalog/biotechnology
About Radiant Insights:
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact:Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: sales@radiantinsights.com
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States
For more information, Visit: http://www.radiantinsights.com
Contact Person: Michelle Thoras
Email: sales@radiantinsights.com
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States
For more information, Visit: http://www.radiantinsights.com
Comments
Post a Comment